Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px
Organisation › Details

Domain Therapeutics (Group)

Domain Therapeutics is a biopharmaceutical company based in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G protein -coupled receptors (GPCRs), one of the most important classes of drug targets. Domain Therapeutics identifies and develops new drug candidates, allosteric modulators and biased ligands through its innovative approach and distinctive technologies. The company provides access to its technologies through research and collaborative agreements. It develops its own pipeline for components up to the stage of optimized lead product for major indications in central nervous system and metabolic disorders. In January 2014, the company established its subsidiary, Domain Therapeutics NA Inc., at the NEOMED Institute in Montreal, Canada. *

 

Period Start 2008-12-01 renamed
  Predecessor Faust Pharmaceuticals S.A.
Products Industry GPCR inhibitor
  Industry 2 CNS drug (neurological drug)
Persons Person Neuville, Pascal (Domain Therapeutics 200812c– CEO)
  Person 2 Malmezat, Stanislas-Léonard (Domain Therapeutics 202205 CFO)
     
Region Region Illkirch
  Country France
  Street 850 Boulevard Sébastien Brant
Bioparc
  City 67400 Illkirch
  Tel +33-3-9040-6150
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: 
     
   
Record changed: 2024-02-12

Advertisement

Picture Berlin Partner Voices Tim Huse BIH Digital Health 650x200px

More documents for Domain Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px




» top